Can we prevent or treat renal dysfunction in chronic heart failure? - Wikidata - awgldk - TriplyDB

Can we prevent or treat renal dysfunction in chronic heart failure?

Can we prevent or treat renal dysfunction in chronic heart failure?

http://www.wikidata.org/entity/Q37893011

about

Clinical use of novel biomarkers in heart failure: towards personalized medicine.

P2860

Q38109588-CA6A04B6-DB09-448D-9A9D-E757B8BA947E

P2860

Can we prevent or treat renal dysfunction in chronic heart failure?

http://www.wikidata.org/entity/Q37893011

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Can we prevent or treat renal dysfunction in chronic heart failure?

@en

Can we prevent or treat renal dysfunction in chronic heart failure?

@nl

type

label

Can we prevent or treat renal dysfunction in chronic heart failure?

@en

Can we prevent or treat renal dysfunction in chronic heart failure?

@nl

prefLabel

Can we prevent or treat renal dysfunction in chronic heart failure?

@en

Can we prevent or treat renal dysfunction in chronic heart failure?

@nl

P1433

Q37893011-E1ADEEE8-0732-4AB1-9248-0735B0A0FC46

P1476

Q37893011-404DB0E7-6610-47E5-8348-88138E6D2903

P2093

Q37893011-C70CC508-EC05-45B7-9298-B1C4CA2C56E5

P2860

Q37893011-002A51C0-CEE0-4E12-B225-C65048130440

Q37893011-09E75C13-EC58-4C63-B16D-3F626C5C7C3B

Q37893011-0BCE7F54-B676-4DBD-AECE-CC8DBB2B21CF

Q37893011-0BDDF177-2119-47C4-A4F7-E6721F79EDDF

Q37893011-1A998211-DA01-4344-A606-1F7B9A7110BC

Q37893011-1F456754-5F79-48AF-A3B4-06F836DE8E50

Q37893011-21B66CCA-6B06-47C1-9FB6-DDFEFE0DA252

Q37893011-2317097E-0C3E-4E8F-AB12-F1AC475C63CD

Q37893011-2436DD35-DC9F-417C-A523-C567C5828AA4

Q37893011-2ABE8AD4-E62B-4616-BF09-8CE7A4486E94

P2888

Q37893011-035B0C7C-3BEA-48B3-8B33-0ECC6AF165FE

P304

Q37893011-4CE9F52F-A1D5-49CC-BC8C-0FFABE752661

P31

Q37893011-9DF6C72B-F912-4DBC-98FE-ACDC35A1D0C5

P356

Q37893011-DB5CBF2E-D672-4120-85B7-9E2B92011F28

P433

Q37893011-E507693D-C8CB-446B-A265-BB1E246C7BE7

P478

Q37893011-3A662108-B1A4-4450-9801-F5CD2F96641A

P50

Q37893011-142AE986-DCAD-4C8A-BA1C-5B304B377210

Q37893011-5E83F7E9-5B13-4E9E-A978-CA99F3975DF9

Q37893011-98EC1D4E-65CB-4368-885A-FE3993FD0078

P577

Q37893011-FEA04DD0-A44D-4392-B266-62569624AB43

P5875

Q37893011-39874E93-7E17-492C-A8F1-806DB4B92F35

P698

Q37893011-B0F00623-4A84-4ED7-8FE7-2BB4830E738D

P921

Q37893011-DD570340-AFA8-4723-9BD3-7C716560E7DC

P356

S10741-011-9264-0

P1433

Heart Failure Reviews

P1476

Can we prevent or treat renal dysfunction in chronic heart failure?

@en

P2093

Daniela Dobre

http://www.w3.org/2001/XMLSchema#string

P2860

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study

Acute administration of diclofenac, but possibly not long term low dose aspirin, causes detrimental renal effects in heart failure patients treated with ACE-inhibitors

Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD)

10-year follow-up of intensive glucose control in type 2 diabetes

Relation of blood urea nitrogen to long-term mortality in patients with heart failure.

Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result.

Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.

Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.

Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial.

Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system.

P2888

s10741-011-9264-0

P304

283-290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10741-011-9264-0

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Patrick Rossignol

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51240701

http://www.w3.org/2001/XMLSchema#string

P698

21695548

http://www.w3.org/2001/XMLSchema#string

P921